|

Physician- and Patient-based Barriers to NGS Testing

RECRUITINGN/ASponsored by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Actively Recruiting
PhaseN/A
SponsorSidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Started2026-01-06
Est. completion2027-09-06
Eligibility
Age18 Years+
SexMALE
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT07209176

Summary

The goal of this study is to improve next-generation sequencing (NGS) testing rates at Johns Hopkins in patients with metastatic prostate cancer. Investigators believe by targeting two barriers, provider-level and patient-level, will improve the testing rate of NGS at Johns Hopkins.

Eligibility

Age: 18 Years+Sex: MALEHealthy volunteers accepted
Inclusion Criteria:

* men diagnosed with metastatic prostate cancer
* seen by Johns Hopkins Medical Oncology as a new patient visit between January 1, 2025 and December 31, 2026

Exclusion Criteria:

\- Patients who have already had NGS testing performed.

Conditions2

CancerMetastatic Prostate Cancer

Locations1 site

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21205
Cathy Marshall, MD410-955-0231chm@jhmi.edu

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.